Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Bayer : hires law firm to probe Monsanto data collection

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/21/2019 | 11:10am EDT
FILE PHOTO: Headquarters and main plant of German pharmaceutical and chemical maker Bayer AG in Leverkusen

BERLIN (Reuters) - Bayer on Tuesday hired law firm Sidley Austin to investigate a Europe-wide data collection scheme run by its Monsanto unit, which targeted journalists, politicians and other stakeholders to influence the debate on pesticides.

Bayer last week admitted that Monsanto, which it acquired for $63 billion last year, had gathered non-public information as part of the campaign, which French media said sought to influence the public debate on pesticides and genetically modified products.

Bayer faces potentially heavy litigation costs from U.S. lawsuits in which plaintiffs claim that its Roundup weedkiller, which contains glyphosate, causes cancer. Bayer disputes this.

In a Q&A document posted on its website on Tuesday, Bayer said U.S public relations and marketing agency FleishmanHillard, on behalf of Monsanto, had mapped stakeholders in France, Germany, Italy, Netherlands, Poland, Spain, and United Kingdom as well as stakeholders related to EU institutions.

Sidley Austin will investigate how many stakeholders were included in those files and whether people from other countries could also be affected, Bayer said.

The law firm would then contact affected people, most of them journalists, politicians and scientists, no later than by the end of the coming week.

French prosecutors said they had opened an inquiry after newspaper Le Monde filed a complaint alleging that Monsanto had kept a file of 200 names in hopes of influencing their positions.

Bayer has ended its PR collaboration with FleishmanHillard, but continues to work with the firm on marketing projects.

Bayer shares have shed more than 40 percent since a first adverse U.S. judgment on Roundup last August, leaving the company with a market capitalization smaller than the price it paid for Monsanto.

(This story removes reference to class-action lawsuits, paragraph 3)

(Reporting by Tassilo Hummel; Editing by Alexandra Hudson)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
04:28aRoche pushes late-comer Tecentriq as new liver cancer option
RE
03:21aBAYER : “Biologicals by Bayer”, leading innovation for organic crop ..
PU
10/17BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
10/16Factbox - How are businesses preparing for a 'no-deal Brexit'?
RE
10/16ATOS : Signs Contract With Bayer for Digital Workplace Services
DJ
10/16BAYER : Animal Health and VLPbio sign global collaboration agreement
PU
10/15BAYER : U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill..
AQ
10/15J&J's Courtroom Losses Pile Up -- WSJ
DJ
10/14Early Blizzard Wallops Vulnerable Crops
DJ
10/14J&J'S JANSSEN : FDA OK's Xarelto in Acutely Ill Medical Patients
DJ
More news
Financials (EUR)
Sales 2019 46 036 M
EBIT 2019 7 933 M
Net income 2019 3 095 M
Debt 2019 37 372 M
Yield 2019 4,36%
P/E ratio 2019 21,1x
P/E ratio 2020 13,4x
EV / Sales2019 2,13x
EV / Sales2020 2,01x
Capitalization 60 840 M
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 79,26  €
Last Close Price 65,24  €
Spread / Highest target 88,5%
Spread / Average Target 21,5%
Spread / Lowest Target -40,6%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG7.73%67 773
JOHNSON & JOHNSON-1.05%337 021
ROCHE HOLDING AG18.88%250 869
MERCK AND COMPANY10.82%216 813
PFIZER-16.47%201 662
NOVARTIS15.10%198 751